Abstract:The expression and methylation of p15INK4B gene and the expression of DNA methyltransferase genes (DNMTs) in the mononuclear cells (MNCs) from bone marrow of 54 cases with hematopoietic malignances were detected by using RT-PCR, Western blot, and methylation-specific PCR. Of the 54 patients, 10 cases were low-risk MDS, 10 cases were high-risk MDS, 10 cases were acute myeloid leukemia (AML), 10 cases were acute lymphocytic leukemia (ALL), 10 cases were chronic myeloid leukemia in chronic phase (CML-CP), and 4 cases were CML in blast phase (CML-BP). 10 normal persons were studied as nective controls. The results showed that the incidence of p15INK4B methylation in cells of high-risk MDS was higher than that in low-risk MDS (6/10 VS 1/10, P=0.003), and the p15INK4B methylation was found to be associated with the down-regulation of the expressions of p15INK4B gene on both mRNA (r=−0.734, p<0.001) and protein (r=−0.664, p=0.001)levels, which indicated that the silencing of p15INK4B gene was in conjunction with hypermethylation in MDS. The expressions of p15INK4B on mRNA level and protein levels were almost detected in the MNCs from bone marrow of normal persons without the p15INK4B methylation. We also found the expression of DNMT3A and DNMT3B in high-risk MDS (densitometry readings respectively: 0.624±0.146, 0.577±0.344) were higher than in low-risk MDS (densitometry readings respectively: 0.487±0.300, 0.338±0.290) (P<0.05). The expression of DNMT1 was higher in the groups of low-risk MDS, high-risk MDS, AL and CML-CP( densitometry readings respectively: 0.487±0.218, 0.697±0.243, 0.706±0.463 and 0.867±0.375) than in normal control (densitometry reading: 0.181±0.312)(P<0.05, figure listed bellow), which indicated that up-regulated DNMTS might contribute to the hypermethylation of p15INK4B, and the higher expressions of de novo methyltransferases DNMT3A and DNMT3B may be related to the disease progression of MDS. The methylation of p15INK4B was also detected in 9/20 of AL cases accompanied by over-expressions of DNMT1, DNMT3A, and DNMT3B (densitometry readings respectively: 0.706±0.463, 1.066±0.547, and 0.530±0.428). The methylation of p15INK4B was detected in 1 of 10 cases of CML-CP patients, but all be detected in 4 case of CML-BP patients. These results indicated that the hypermethylation of p15INK4B gene may be one of the most common genetic event in pathogenesis of high-risk MDS, acute leukemia, and blast phase of CML. Furthermore, DNMT3A and DNMT3B were substantially over-expressed in the bone marrow cells of these patients. which might play an important role in the transformation from MDS to acute leukemia.

Hypermethylation of CPG island of p15 and p16 genes in multiple myeloma

Study on Methylation of P15ink4b Gene and Its Mechanisms in Patients with Myelodysplastic Syndrome and Leukemia.

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.

Methylation of P16 Promotor's CpG Region and Its Association with Clinic Pathological Characteristics of Gliomas

Detection of Hypermethylation of P16 Gene from Colorectal Cancer Patient

Methylation induces protocadherin-10 silence in multiple myeloma

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

P16 CpG Region Methylation of the Colorectal Cancer and Its Association with Clinicopathological Characteristics

[Detection of Methylation Levels of Multi-Genes by Real-Time PCR in Patients with Myelodysplastic Syndrome].

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR

DNA Methylation and Mutiple Myeloma

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Methylation Status of the Long Control Region of Hpv 16 in Clinical Cervical Specimens

Aberrant Methylation in CpG Islands of P15 and P16 Tumor Suppressor Genes in Pancreatic Cancer Tissue

Methylation Status of P16 Gene in Colorectal Carcinoma and Normal Colonic Mucosa.

Deletion of the P15 Gene and Promoter Methylation in the Bone Marrow of Patients with Myelodysplastic Syndromes

Hypermethylation of Multiple Tumor-Related Genes in Gastric Carcinoma and Adjacent Normal Tissues

DNA methylation of microRNA genes in multiple myeloma.